What is Jorgensen Laboratories?
Jorgensen Laboratories operates as a dedicated veterinary distributor, committed to providing exceptional service and a comprehensive range of products to its clientele. The company emphasizes ease of access to essential resources, including regional manager contact information and product literature, all readily available on its website. This focus on customer support and product accessibility positions Jorgensen Laboratories as a reliable partner within the veterinary supply chain, aiming for customer satisfaction through variety and quality.
How much funding has Jorgensen Laboratories raised?
Jorgensen Laboratories has raised a total of $37.4M across 2 funding rounds:
Debt
$1M
Private Equity
$36.4M
Debt (2020): $1M with participation from PPP
Private Equity (2022): $36.4M led by Main Street Capital
Key Investors in Jorgensen Laboratories
Main Street Capital
Main Street Capital is a principal investment firm specializing in providing long-term debt and equity capital to lower middle market companies. Their investments typically support buyouts, recapitalizations, growth financings, and acquisitions across diverse sectors.
What's next for Jorgensen Laboratories?
The recent major strategic investment signifies a pivotal moment for Jorgensen Laboratories, likely enabling expansion of its distribution network, enhancement of its product catalog, and further development of its customer support infrastructure. This capital infusion is expected to fuel continued growth and solidify its market position. The company's strategic focus on operational excellence and customer satisfaction, coupled with this significant backing, suggests a robust future outlook for scaling its enterprise-level operations and deepening its impact within the veterinary industry.
See full Jorgensen Laboratories company page
